Cocrystal Pharma (COCP) Interest Coverage Ratio (2010 - 2026)
Cocrystal Pharma (COCP) posted Interest Coverage Ratio of 107.09 for Q1 2026, up 685.59% sequentially from 13.63 in Q4 2025, and up 69.26% YoY from 63.27 in Q1 2025.
Cocrystal Pharma (COCP) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Interest Coverage Ratio for 17 years, with the latest figure at 107.09 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 69.26% year-over-year to 107.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.85 (up 65.54% YoY) and the FY2025 annual result came in at 13.38, up 40.95% from the prior year.
- Interest Coverage Ratio rose to 107.09 in Q1 2026 per COCP's latest filing, from 13.63 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 107.09 in Q1 2026 and troughed at 939.54 in Q2 2022.
- A 5-year average of 72.24 and a median of 6.09 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio tumbled 1299.0% in 2022, then soared 415.26% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 299.68 in 2022, then soared by 108.65% to 25.92 in 2023, then tumbled by 116.68% to 4.32 in 2024, then jumped by 415.26% to 13.63 in 2025, then jumped by 685.59% to 107.09 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 107.09, 13.63, and 8.63 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | 318.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 |
| Mar 31, 2026 | 107.09 |
| Dec 31, 2025 | 13.63 |
| Sep 30, 2025 | -8.63 |
| Jun 30, 2025 | -7.87 |
| Mar 31, 2025 | 63.27 |
| Dec 31, 2024 | -4.32 |
| Sep 30, 2024 | -12.15 |
| Jun 30, 2024 | -2.56 |
| Mar 31, 2024 | 18.90 |
| Dec 31, 2023 | 25.92 |
| Sep 30, 2023 | 13.88 |
| Jun 30, 2023 | -23.84 |
| Mar 31, 2023 | -91.27 |
| Sep 30, 2022 | -299.68 |
| Jun 30, 2022 | -939.54 |
| Mar 31, 2022 | -8.69 |
| Sep 30, 2021 | -74.58 |
| Jun 30, 2021 | -67.16 |
| Mar 31, 2021 | -40.26 |